Search Results - "Visani, Giuseppe"
-
1
BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
Published in Frontiers in oncology (24-09-2019)“…Not all chronic myeloid leukemia (CML) patients are cured with tyrosine kinase inhibitors (TKIs), and a proportion of them develop resistance. Recently,…”
Get full text
Journal Article -
2
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia
Published in The New England journal of medicine (13-05-2021)“…The rare indolent B-cell cancer hairy-cell leukemia is often driven by activating BRAF mutations. BRAF inhibition induces responses, but relapse is common when…”
Get full text
Journal Article -
3
Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients
Published in Frontiers in oncology (06-09-2021)“…The efficacy of Covid-19 vaccine in hematopoietic stem cell transplantation (HSCT) recipients is still unknown. We planned a prospective study to evaluate the…”
Get full text
Journal Article -
4
Immunotherapy in Acute Myeloid Leukemia: Where We Stand
Published in Frontiers in oncology (10-05-2021)“…In the past few years, our improved knowledge of acute myeloid leukemia (AML) pathogenesis has led to the accelerated discovery of new drugs and the…”
Get full text
Journal Article -
5
Treatment options for acute myeloid leukemia patients aged <60 years
Published in Frontiers in oncology (05-10-2022)“…Treatment of acute myeloid leukemia (AML) has changed over the last few years, after the discovery of new drugs selectively targeting AML blasts. Although 3/7…”
Get full text
Journal Article -
6
SARS-CoV-2 impact in a community-based hematological ward in an Italian Red Zone
Published in Annals of hematology (01-07-2020)Get full text
Journal Article -
7
The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia
Published in Frontiers in oncology (25-10-2019)“…Mesenchymal stromal cells (MSCs) have, for a long time, been recognized as pivotal contributors in the set up and maintenance of the hematopoietic stem cell…”
Get full text
Journal Article -
8
Antigen Receptors Gene Analysis for Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia: The Role of High Throughput Sequencing
Published in Hemato (01-03-2023)“…The prognosis of adult acute lymphoblastic leukemia (ALL) is variable but more often dismal. Indeed, its clinical management is challenging, current therapies…”
Get full text
Journal Article -
9
-
10
Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia
Published in Frontiers in oncology (09-10-2019)“…In solid tumors and hematological malignancies, including acute myeloid leukemia, some chemotherapeutic agents, such as anthracyclines, have proven to activate…”
Get full text
Journal Article -
11
Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Systemic immune stimulation has been associated with increased risk of myeloid malignancies, but the pathogenic link is unknown. We demonstrate in animal…”
Get full text
Journal Article -
12
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients
Published in Blood (22-09-2011)“…We designed a phase 1-2 study to evaluate the safety and the efficacy of increasing doses of bendamustine (160 mg/m2, 180 mg/m2, and 200 mg/m2 given on days −7…”
Get full text
Journal Article -
13
Hematopoietic and leukemic stem cells homeostasis: the role of bone marrow niche
Published in Exploration of targeted anti-tumor therapy (01-01-2024)“…The bone marrow microenvironment (BMM) has highly specialized anatomical characteristics that provide a sanctuary place for hematopoietic stem cells (HSCs)…”
Get full text
Journal Article -
14
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib
Published in Frontiers in oncology (13-05-2021)“…Tyrosine kinase inhibitors (TKIs) have radically changed the outcome of chronic myeloid leukemia (CML) patients in the last 20 years. Moreover, the advent of…”
Get full text
Journal Article -
15
Molecular Profiling of Kenyan Acute Myeloid Leukemia Patients
Published in Frontiers in genetics (28-06-2022)“…Acute myeloid leukemia (AML) is an infrequent disease, and it is associated with high morbidity and mortality. It harbors a unique configuration of cytogenetic…”
Get full text
Journal Article -
16
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma
Published in Frontiers in oncology (02-09-2021)“…Altered cellular energetic metabolism has recently emerged as important feature of neoplastic cells. Indeed, interfering with cancer cell metabolism might…”
Get full text
Journal Article -
17
Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia
Published in Leukemia & lymphoma (01-02-2011)Get full text
Journal Article -
18
PB2379: SPECIFIC ALTERATIONS IN MEMBRANE LIPID LEVELS AS POTENTIAL BIOMARKERS IN DLBCL PATIENTS
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
19
Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation
Published in Blood (01-07-2002)“…To identify the role of iron overload in the natural history of liver fibrosis, we reviewed serial hepatic biopsy specimens taken annually from patients cured…”
Get full text
Journal Article -
20
Thiotepa‐busulfan‐fludarabine Compared to Treosulfan‐based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMT
Published in HemaSphere (01-10-2023)“…We conducted a registry analysis including adult acute myeloid leukemia (AML) patients in remission who had received thiotepa, busulfan, and fludarabine (TBF)…”
Get full text
Journal Article